Related Experiment Video
Updated: Sep 11, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Endovascular treatment for Moyamoya-associated intracranial aneurysms: a systematic review and meta-analysis
Mariana Letícia de Bastos Maximiano1, Ocílio Ribeiro Gonçalves2, Pedro Lucas Machado Magalhães3
1Federal Fluminense University, Niterói, Brazil marianabastosmaximiano@gmail.com.
Background:
Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of the distal internal carotid arteries, leading to increased collateral flow and the development of an abnormal vascular network, which imposes shear stress on small vessels and increases the risk of aneurysm formation. Endovascular treatment (EVT) has emerged as a potential approach for managing MMD-associated intracranial aneurysms (MMD-IA), but its safety and efficacy remain unclear.
Objective:
This systematic review and meta-analysis aimed to evaluate the safety, efficacy, and long-term outcomes of EVT in patients with MMD-IA.
Methods:
A comprehensive search was conducted across PubMed, Embase, and Web of Science, adhering to PRISMA guidelines. Studies reporting clinical and angiographic outcomes for EVT of MMD-IA were included. The primary outcomes were complete aneurysm occlusion, functional outcomes, procedural complications, and recurrence rates. Pooled analyses with 95% confidence intervals (95% CIs) were conducted, with heterogeneity assessed using I² statistics, and a random-effects model was applied.
Results:
Seventeen studies, comprising 506 patients (36.33% female; mean age: 49.24±10.91 years) with aneurysms were included. Of these, 181 patients underwent EVT. The pooled complete occlusion rate was 86.46% (95% CI: 39.28 to 98.44) immediately after embolization and 84.51% (95% CI: 75.67 to 90.54) at last follow-up. Procedure-related complications were 15.27% (95% CI: 9.88 to 22.85) and the prevalence of subarachnoid hemorrhage after the procedure was 5.25% (95% CI: 2.20 to 12.05). The prevalence of ischemic procedural complications was estimated at 8.69% (95% CI: 4.49 to 16.16). Functional independence (modified Rankin Scale (mRS) 0-2) was achieved in 86.93% (95% CI: 73.55 to 94.09) of cases at follow-up. The aneurysm recurrence rate was 8.08% (95% CI: 3.05 to 19.69), emphasizing the need for long-term monitoring.
Conclusions:
EVT appears to be a safe and effective treatment for MMD-IA, demonstrating high occlusion rates and favorable functional outcomes. However, the risk of aneurysm recurrence highlights the importance of long-term follow-up. Further large studies are necessary to confirm these findings and optimize treatment strategies for this complex condition.
Insights
Endovascular treatment (EVT) is a safe and effective option for moyamoya disease-associated intracranial aneurysms (MMD-IA), showing high occlusion rates and good functional outcomes. Long-term monitoring is crucial due to the risk of aneurysm recurrence.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Radiology
Background:
- Moyamoya disease (MMD) involves progressive stenosis of brain arteries, increasing aneurysm risk.
- MMD-associated intracranial aneurysms (MMD-IA) pose significant clinical challenges.
- The role of endovascular treatment (EVT) for MMD-IA requires further clarification.
Purpose of the Study:
- To systematically review and perform a meta-analysis on the safety and efficacy of EVT for MMD-IA.
- To evaluate functional outcomes and complication rates associated with EVT in MMD-IA patients.
- To assess long-term outcomes, including aneurysm recurrence, after EVT for MMD-IA.
Main Methods:
- Comprehensive literature search across major databases (PubMed, Embase, Web of Science) following PRISMA guidelines.
- Inclusion of 17 studies with 506 patients diagnosed with MMD-IA, focusing on those treated with EVT.
- Pooled analysis of complete occlusion rates, functional independence (mRS 0-2), procedural complications, and recurrence rates using a random-effects model.
Main Results:
- EVT achieved a pooled complete occlusion rate of 86.46% immediately post-procedure and 84.51% at last follow-up.
- Procedure-related complications occurred in 15.27% of cases, with subarachnoid hemorrhage at 5.25% and ischemic complications at 8.69%.
- Functional independence was achieved in 86.93% of patients, while the aneurysm recurrence rate was 8.08%.
Conclusions:
- EVT demonstrates safety and efficacy in treating MMD-IA, with high occlusion rates and favorable functional outcomes.
- The observed recurrence rate underscores the necessity for diligent long-term patient monitoring.
- Further extensive research is warranted to solidify these findings and refine EVT strategies for MMD-IA.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management

